Anlotinib Recruiting Phase 3 Trials for Synovial Sarcoma / Soft-Tissue Sarcoma / Alveolar Soft Part Sarcoma (ASPS) / Leiomyosarcomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03016819A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma